Welcome to our dedicated page for SELECTIS HEALTH SEC filings (Ticker: GBCS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Selectis Health Inc. filings document a Utah public company that owns and operates healthcare facilities through subsidiaries and reports material events tied to skilled nursing facility assets. Recent 8-K disclosures cover completed dispositions of Georgia skilled nursing facilities, related purchase and sale agreements, subsidiary property interests, proceeds, escrows, debt repayment and other asset-sale terms.
The company’s SEC record also includes governance disclosures for board appointments and resignations, compensatory arrangements for directors, and changes involving executive or board roles. Capital-structure filings describe modifications to senior secured promissory notes, warrant terms and securityholder rights, while Form 12b-25 notices address annual-report timing and financial-statement preparation.
Selectis Health, Inc. (GBCS) reports that an affiliate of Black Pearl Equities has successfully completed its tender offer to acquire the company for $5.75 per share in cash. As of the August 31, 2026 expiration, 2,789,027 shares, or about 90.93% of outstanding common stock, were validly tendered and accepted for payment.
Under the Merger Agreement, a follow-on merger under Utah law will convert each remaining share into the right to receive the same $5.75 cash consideration, after which Selectis will become an indirect wholly owned subsidiary of Black Pearl and plans to deregister its shares and cease OTCQB quotation. To fund the approximately $17.6 million aggregate offer and merger consideration plus fees, Selectis, Black Pearl Equities II, LLC and Tortuga Acquisition Sub, Inc. entered into a new $18.23 million secured term loan facility at a fixed 5.0% interest rate maturing August 28, 2031. Following the change in control, board and management changes include the resignation of director Lance J. Baller and interim CEO Krystal Eckhart (who remains interim CFO) and the appointment of Abraham Schwartz and Zalman Schapiro as directors.
SELECTIS HEALTH, Inc. (GBCS) reports the final results of a cash tender offer by Black Pearl Equities affiliates to acquire all outstanding common shares at $5.75 per share. The offer expired at 5:00 p.m. New York City time on August 31, 2026.
The depositary advised that 2,789,027 shares were validly tendered and not withdrawn, representing approximately 90.93% of the outstanding shares, so the Minimum Tender Condition was satisfied and all such shares have been accepted for payment. The acquiror expects to complete a short-form merger under the Utah Revised Business Corporation Act, after which each remaining untendered share will be converted into the right to receive $5.75 in cash, matching the tender offer price.
SELECTIS HEALTH, Inc. (GBCS) is the subject of a cash tender offer by Black Pearl Equities, LLC and its affiliates, which has been amended to extend key deadlines. The offer seeks to purchase all outstanding common shares at $5.75 per share in cash, without interest and subject to tax withholding.
The expiration of the offer is extended from 5:00 p.m. New York City time on August 27, 2026 to 5:00 p.m. New York City time on August 31, 2026, unless further extended. As of August 27, 2026, 2,786,482 shares had been validly tendered and not withdrawn. The deadline to deliver shares using the guaranteed delivery procedures is extended to 5:00 p.m. New York City time on September 1, 2026, and the deadline for stockholders to deliver written demands for appraisal rights under Utah law is correspondingly extended.
SELECTIS HEALTH, Inc. (GBCS) is the subject of an amended tender offer by Black Pearl Equities, LLC, its subsidiaries, and affiliated persons. The amendment extends the cash tender offer to purchase all outstanding common shares at $5.75 per share.
The offer expiration is extended from 5:00 p.m. New York City time on August 24, 2026 to 5:00 p.m. on August 27, 2026, with the guaranteed delivery deadline extended to 5:00 p.m. on August 28, 2026. As of August 24, 2026, 2,773,036 shares had been validly tendered and not withdrawn. The deadline to deliver written demands for appraisal rights under Utah law is correspondingly extended.
Selectis Health, Inc. (GBCS) reported Q2 2026 results showing a sharp shift driven by asset sales and balance sheet repair. For the three months ended June 30, 2026, healthcare revenue fell to $4.6 million from $10.4 million, mainly due to selling four Georgia facilities. Despite lower operating scale, a $10.2 million gain on the May sale of two Georgia facilities and prior January sales produced net income of $8.1 million for the quarter and $14.6 million for the first half, versus losses in 2025. Basic EPS was $2.65 for the quarter and $4.77 year-to-date.
Total debt (net of discount) decreased to $17.0 million from $31.0 million, and stockholders’ position moved from a $(6.6) million deficit at December 31, 2025 to positive equity of $8.0 million at June 30, 2026, supported by asset sale gains and debt paydowns. Cash, cash equivalents and restricted cash increased to $7.9 million, aided by $28.9 million of Georgia sale proceeds, but operating cash flow was negative $4.3 million for the first half.
Management states that substantial doubt exists about the company’s ability to continue as a going concern due to historical losses and projected cash needs. The company discloses continuing material weaknesses in internal control over financial reporting. On June 22, 2026, Selectis entered into a Merger Agreement under which a subsidiary of Black Pearl Equities II, LLC will launch a cash tender offer to acquire all outstanding common shares at $5.75 per share, subject to a 70% minimum tender and other conditions, followed by a cash merger.
Selectis Health, Inc. (symbol GBCS) is the subject of a cash tender offer by Black Pearl Equities, LLC and its subsidiaries to acquire all outstanding common shares at $5.75 per share. This amendment reports a change in the offer timetable and current tender levels.
The offer expiration has been extended from 5:00 p.m., New York City time, on August 17, 2026 to 5:00 p.m. on August 24, 2026, unless further extended. The deadline to deliver shares under the guaranteed delivery procedures is extended to 5:00 p.m. on August 25, 2026, and the deadline for stockholders to deliver written demands for appraisal rights under Utah law is correspondingly extended. As of August 17, 2026, 2,769,282 shares had been validly tendered and not withdrawn.
Selectis Health, Inc. (GBCS) notified regulators that it will not file its Quarterly Report on Form 10‑Q for the period ended June 30, 2026 within the prescribed time. The company states it has not yet completed preparation of its unaudited financial statements for the fiscal quarter, which prevents timely filing.
The notice is made under Rule 12b‑25, which provides a limited extension when a report cannot be filed without unreasonable effort or expense. The company identifies no specific items or transactions in this notice beyond the delayed completion of its quarterly financial statements.
Black Pearl Equities, LLC, through its subsidiaries, is amending its tender offer to acquire all outstanding shares of Selectis Health, Inc. common stock for $5.75 per share in cash, without interest and subject to tax withholding. The offer’s expiration is extended from 5:00 p.m. New York City time on August 10, 2026 to 5:00 p.m. on August 17, 2026, unless further extended. As of August 10, 2026, 2,807,869 shares had been validly tendered and not withdrawn. The guaranteed delivery deadline is extended to 5:00 p.m. on August 18, 2026, and the deadline to deliver written demands to exercise appraisal rights under Utah law is correspondingly extended.
Black Pearl Equities, LLC, through its wholly owned subsidiaries Black Pearl Equities II, LLC and Tortuga Acquisition Sub, Inc., is pursuing a cash tender offer to acquire all issued and outstanding shares of Selectis Health, Inc. common stock. The offer price is $5.75 per Share in cash, without interest and subject to any required tax withholding, on the terms and conditions set out in the Offer to Purchase dated July 13, 2026 and the related Letter of Transmittal.
This amendment updates the existing Schedule TO filing by adding an exhibit: a transcript of a pre-recorded outreach message directed to registered stockholders of Selectis Health. The amendment does not change the stated offer price or core terms of the tender offer; it primarily expands the disclosure record of communications made to stockholders in connection with the offer.
Selectis Health, Inc. is the subject of a cash tender offer by Black Pearl Equities, LLC, Black Pearl Equities II, LLC, and Tortuga Acquisition Sub, Inc. The offer seeks to purchase all issued and outstanding common shares at $5.75 per share in cash, without interest and subject to any required tax withholding, under an Offer to Purchase dated July 13, 2026.
This amendment does not change the economic terms of the offer. It revises wording in the legal and regulatory approvals section by replacing the phrase “OK Required Approvals” with “Required OK Approvals,” leaving all other terms and conditions of the tender offer unchanged.